Literature DB >> 8923597

Gastrointestinal manifestations of scleroderma.

M A Young1, S Rose, J C Reynolds.   

Abstract

The gastrointestinal tract is commonly involved in SSc. The esophagus is the most frequently affected, followed by the anorectal region, the small bowel, stomach, and colon. Smooth muscle atrophy and to a lesser degree fibrosis is the underlying defect responsible for the resulting abnormalities. These smooth muscle alterations have a significant impact on gastrointestinal motility, which results in secondary disorders of GER, pseudo-obstruction, bacterial overgrowth, and disordered bowel functions. The clinical presentation for these conditions ranges from asymptomatic to life-threatening. Thus, gastrointestinal evaluation and treatment of these conditions is an important aspect in the management of patients with SSc.

Entities:  

Mesh:

Year:  1996        PMID: 8923597     DOI: 10.1016/s0889-857x(05)70302-1

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

1.  Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.

Authors:  T A McNearney; H S Sallam; S E Hunnicutt; D Doshi; D E Wollaston; M D Mayes; J D Z Chen
Journal:  Neurogastroenterol Motil       Date:  2009-06-30       Impact factor: 3.598

2.  Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.

Authors:  Kayoko Oda; Ryuichi Iwakiri; Megumi Hara; Kazuyo Watanabe; Akiko Danjo; Ryo Shimoda; Atsushi Kikkawa; Akifumi Ootani; Hiroyuki Sakata; Seiji Tsunada; Kazuma Fujimoto
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Atypical presentation of scleroderma in infancy.

Authors:  Navin Mishra; Devendra Shrestha; Rakesh Babu Poudyal; K C Shiva Raj
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

4.  Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function.

Authors:  P Iovino; G Valentini; C Ciacci; A De Luca; F Tremolaterra; F Sabbatini; E Tirri; G Mazzacca
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

5.  Lung atelectasis secondary to massive esophageal dilation in a patient with scleroderma.

Authors:  Charles St-Arnaud; Nicole Bouchard; Luc Lanthier
Journal:  Can Respir J       Date:  2010 Jul-Aug       Impact factor: 2.409

6.  A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide.

Authors:  Ryo Kato; Kiyokazu Nakajima; Tsuyoshi Takahashi; Yasuhiro Miyazaki; Tomoki Makino; Yukinori Kurokawa; Makoto Yamasaki; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Surg Case Rep       Date:  2016-04-13

7.  Four Cases of Pneumatosis Cystoides Intestinalis Complicated by Connective Tissue Diseases.

Authors:  Eiji Suzuki; Takashi Kanno; Momoko Hazama; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

8.  Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging.

Authors:  Ching Lam; David S Sanders; Peter Lanyon; Klara Garsed; Stephen Foley; Susan Pritchard; Luca Marciani; Caroline L Hoad; Carolyn Costigan; Penny Gowland; Robin Spiller
Journal:  United European Gastroenterol J       Date:  2019-06-21       Impact factor: 4.623

9.  Incidence, prevalence and clinical manifestations of systemic sclerosis in dukagjini plain.

Authors:  Ismet H Bajraktari; Idriz Berisha; Merita Berisha; Valton Saiti; Halit Bajraktari
Journal:  Mater Sociomed       Date:  2013-03

10.  Oral manifestations of Systemic Sclerosis and Correlation with anti-Topoisomerase I Antibodies (SCL-70).

Authors:  Ismet H Bajraktari; Avni Kryeziu; Fadil Sherifi; Halit Bajraktari; Ali Lahu; Genc Bajraktari
Journal:  Med Arch       Date:  2015-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.